Secondary Antibodies

Immunogen amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein

General description Anti-ALS2CR4 Antibody detects endogenous levels of total ALS2CR4 protein. Immunogen The antiserum was produced against synthesized peptide derived from human ALS2CR4.

Immunogen ALS2CR8 (NP_079020.12, 1 a.

General description Anti-ALS2CR8 Antibody detects endogenous levels of total ALS2CR8 protein. Immunogen The antiserum was produced against synthesized peptide derived from human ALS2CR8.

Immunogen AMDHD2 (NP_057028.2, 1 a.

Immunogen The immunogen for anti-AMHR2 antibody: synthetic peptide derected towards the N terminal of human AMHR2 Biochem/physiol Actions On ligand binding, Amhr2 forms a receptor complex consisting of two type II and two type I transmembrane

ANTI-AMHR2 ANTIBODY CLONE 8Z8X4 RABBIT MONOCLONAL

Immunogen adhesion molecule with Ig-like domain 2 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a

Immunogen adhesion molecule with Ig-like domain 2 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive

Immunogen adenosine monophosphate deaminase 2 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result,

Adenosine monophosphate deaminase 2 (AMPD2) is made up of nineteen exons and eighteen intervening sequences. It is expressed in nonmuscle tissues and cells.

Immunogen adenosine monophosphate deaminase 2 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result,